Literature DB >> 9786022

Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log.

A Christopoulos1.   

Abstract

It is quite common to see experimental data analysed according to a variety of models of ligand-receptor interaction. Often, parameters derived from such models are compared statistically. The most commonly employed statistical analyses contain explicit assumptions about the underlying distributions of the model parameters being compared, yet the validity of these assumptions is not often ascertained. In this article, Arthur Christopoulos describes a general approach to Monte Carlo simulation of data, and outlines how the analysis of such simulated data may be used to address the question of the distribution of model parameters. The results of such an exercise can guide the researcher to the appropriate choice of statistical test or data transform.

Mesh:

Substances:

Year:  1998        PMID: 9786022     DOI: 10.1016/s0165-6147(98)01240-1

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  66 in total

1.  Synthesis and characterization of a novel tritiated KATP channel opener with a benzopyran structure.

Authors:  P W Manley; C Löffler-Walz; U Russ; A Hambrock; T Moenius; U Quast
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Binding and effect of K ATP channel openers in the absence of Mg2+.

Authors:  Ulrich Russ; Ulf Lange; Cornelia Löffler-Walz; Annette Hambrock; Ulrich Quast
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

3.  Foot equilibrium position controls partition of voluntary command to antagonists during foot oscillations.

Authors:  Fausto Baldissera; Paolo Cavallari; Roberto Esposti
Journal:  Exp Brain Res       Date:  2003-12-19       Impact factor: 1.972

4.  A Monod-Wyman-Changeux mechanism can explain G protein-coupled receptor (GPCR) allosteric modulation.

Authors:  Meritxell Canals; J Robert Lane; Adriel Wen; Peter J Scammells; Patrick M Sexton; Arthur Christopoulos
Journal:  J Biol Chem       Date:  2011-11-15       Impact factor: 5.157

5.  Structural determinants of allosteric agonism and modulation at the M4 muscarinic acetylcholine receptor: identification of ligand-specific and global activation mechanisms.

Authors:  Vindhya Nawaratne; Katie Leach; Christian C Felder; Patrick M Sexton; Arthur Christopoulos
Journal:  J Biol Chem       Date:  2010-04-20       Impact factor: 5.157

Review 6.  Matching models to data: a receptor pharmacologist's guide.

Authors:  David A Hall; Christopher J Langmead
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

7.  Impact of species variability and 'probe-dependence' on the detection and in vivo validation of allosteric modulation at the M4 muscarinic acetylcholine receptor.

Authors:  S Suratman; K Leach; Pm Sexton; Cc Felder; Re Loiacono; A Christopoulos
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

8.  A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors.

Authors:  Praseeda Mullasseril; Kasper B Hansen; Katie M Vance; Kevin K Ogden; Hongjie Yuan; Natalie L Kurtkaya; Rose Santangelo; Anna G Orr; Phuong Le; Kimberly M Vellano; Dennis C Liotta; Stephen F Traynelis
Journal:  Nat Commun       Date:  2010-10-05       Impact factor: 14.919

9.  GluN1 splice variant control of GluN1/GluN2D NMDA receptors.

Authors:  Katie M Vance; Kasper B Hansen; Stephen F Traynelis
Journal:  J Physiol       Date:  2012-05-28       Impact factor: 5.182

10.  Inhibition of skeletal muscle sodium currents by mexiletine analogues: specific hydrophobic interactions rather than lipophilia per se account for drug therapeutic profile.

Authors:  Annamaria De Luca; Sophie Talon; Michela De Bellis; Jean-François Desaphy; Carlo Franchini; Giovanni Lentini; Alessia Catalano; Filomena Corbo; Vincenzo Tortorella; Diana Conte-Camerino
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-01-25       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.